EnteroMedics Inc.
ETRM
ETRM was delisted on the 20th of October, 2017.
26 hedge funds and large institutions have $1.14M invested in EnteroMedics Inc. in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 5 closing their positions.
25,000% more call options, than puts
Call options by funds: $251K | Put options by funds: $1K
700% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 1
200% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 5
142% more capital invested
Capital invested by funds: $473K → $1.14M (+$671K)
44% more funds holding
Funds holding: 18 → 26 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$341K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$155K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$134K |
| 4 |
EPM
Equitec Proprietary Markets
Chicago,
Illinois
|
+$95.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$82.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$326K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$67K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$3.76K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GT
26
Glenmede Trust
Philadelphia,
Pennsylvania
| – | +$15 | +2 | New |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$104 | +14 | +700% |
|
|
LTFS
28
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | +$222 | +30 | New |
|
ETRM Hedge Fund Activity: Q1 2017 in Review
26 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q1 2017, worth a combined $1.14M — up 142% from $473K a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new ETRM positions and 5 closed out — a net gain of 10 holders — while 8 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $341K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $326K sold.
- 26 institutional investors held EnteroMedics Inc. (ETRM) as of Q1 2017, up from 18 in Q4 2016.
- Funds reported $1.14M of EnteroMedics Inc. stock for Q1 2017, up 142% quarter-over-quarter.
- 15 funds opened new EnteroMedics Inc. positions in Q1 2017 and 5 closed out, a net change of +10 holders.
- The largest EnteroMedics Inc. buyer in Q1 2017 was Morgan Stanley, an estimated $341K added.
- The largest EnteroMedics Inc. seller in Q1 2017 was Renaissance Technologies, an estimated $326K sold.
Based on aggregated 13F filings for Q1 2017.